2026-04-17T03:39:00Zhttps://recercat.cat/oai/request

oai:recercat.cat:11351/111892025-10-24T10:34:09Zcom_2072_378070com_2072_378040col_2072_378092

2025-10-24T10:34:09Z urn:hdl:11351/11189 Development and Psychometric Validation of the Breast Cancer Stigma Assessment Scale for Women with Breast Cancer and Its Survivors Cenit-García, Judit Buendia Gilabert, Carolina Contreras-Molina, Carmen Fernandez Castillo, Rafael Puente-Fernandez, Daniel Garcia-Caro, Maria Paz Mama - Càncer Psicometria Estigma (Psicologia social) DISEASES::Neoplasms::Neoplasms by Site::Breast Neoplasms PSYCHIATRY AND PSYCHOLOGY::Behavioral Disciplines and Activities::Psychological Tests::Psychometrics NAMED GROUPS::Persons::Survivors::Cancer Survivors PSYCHIATRY AND PSYCHOLOGY::Behavior and Behavior Mechanisms::Behavior::Social Behavior::Social Stigma ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de la mama PSIQUIATRÍA Y PSICOLOGÍA::disciplinas y actividades conductuales::pruebas psicológicas::psicometría DENOMINACIONES DE GRUPOS::personas::sobrevivientes::supervivientes de cáncer PSIQUIATRÍA Y PSICOLOGÍA::conducta y mecanismos de la conducta::conducta::conducta social::estigma social Neoplàsia de mama; Supervivents de càncer; Estigma social Neoplasia de mama; Supervivientes de cáncer; Estigma social Breast neoplasm; Cancer survivors; Social stigma Background: The increase in breast cancer cases and breast cancer survival makes it advisable to quantify the impact of the health-related stigma of this disease. Purpose/Objectives: To develop and validate a breast cancer stigma scale in Spanish. Methods: Women diagnosed with, or survivors of, breast cancer were included. The development of the Breast Cancer Stigma Assessment Scale (BCSAS) involved both a literature review and personal interviews. Content validity was assessed using a Delphi study and a pilot test; construct validity was evaluated using an exploratory factor analysis; and convergent validity was assessed using six scales. Cronbach’s α internal consistency and test-retest reliability were used to determine the reliability of the scales. Results: 231 women responded to the 28-item scale. The BCSAS showed good reliability, with α = 0.897. Seven factors emerged: concealment (α = 0.765), disturbance (α = 0.772), internalized stigma (α = 0.750), aesthetics (α = 0.779), course (α = 0.599), danger (α = 0.502), and origin (α = 0.350). The test-retest reliability was 0.830 (p < 0.001). Significant correlation was observed with event centrality (r = 0.701), anxiety–depression (r = 0.668), shame (r = 0.645), guilt (r = 0.524), and quality of life (r = −0.545). Conclusions: The BCSAS is a reliable and valid measure of stigma in women with breast cancer and its survivors. It could be useful for detecting stigma risk and establishing psychotherapeutic and care priorities. 2025-10-24T10:34:09Z 2025-10-24T10:34:09Z 2024-03-14T10:01:17Z 2024-03-14T10:01:17Z 2024-02-06 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://hdl.handle.net/11351/11189 Healthcare;12(4) https://doi.org/10.3390/healthcare12040420 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess MDPI Scientia